International Pharma and Medical Device Compliance Congress XII Features Annual CCO Roundtable; Early Bird Ends on 3/30
  • Sponsored by ETHICS, the International Society of Healthcare Compliance Professionals
  • Media Partner: Life Science Compliance Update
  • May 14 - 16, 2018
  • Onsite at the Hotel Savoyen Vienna, Austria
  • Vienna, Austria
  • www.InternationalPharmaCongress.com
PRESS RELEASE
Phone: 800-503-8171
Email: registration@hcconferences.com
Website: www.InternationalPharmaCongress.com
AGENDA & BROCHURE NOW AVAILABLE
Click here to view the agenda.
Click here to view the brochure.

EARLY BIRD REGISTRATION
- SAVE UP TO €400 -
Register by Friday, March 30, 2018 and save up to €400.
Click here to register.

FEATURING ANNUAL CHIEF COMPLIANCE OFFICERS ROUNDTABLE WITH

Julie Bonhomme
Legal Affairs and Compliance Deputy Director, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium
Suzanne Durdevic, LLM
Senior Director, General Counsel Europe, Boston Scientific International; Chair, Legal Affairs Committee, MedTech Europe; Member, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Paris, France
Tomasz Kruk
Head of Compliance, Vifor Pharma; Former Director, International Compliance, Mallinckrodt Pharmaceuticals; Former Director, Global Ethics and Compliance, Actavis plc (now Allergan), Zurich, Switzerland

Evelyne Lemaire, MA
Head of Compliance, Europe and Canada, Takeda Pharmaceuticals International GmbH, Zurich, Switzerland
Thomas J. Schumacher, JD
Vice President and Global Chief Ethics and Compliance Officer, Medtronic; Awardee, 2017 PwC MedTech Ethical Leadership Award, Fridley, MN, USA
Mariusz Witalis
Partner, Fraud Investigation & Dispute Services, EY, Warsaw, Poland (Moderator)

SPECIAL RATES AVAILABLE FOR

VIENNA, AUSTRIA -- PHARMA UPDATE NEWS SERVICE™ -- MARCH 14, 2018: The Twelfth International Pharmaceutical and Medical Device Compliance Congress, www.InternationalPharmaCongress.com, will be held May 14 - 16, 2018 at the Hotel Savoyen, Vienna, Austria.

KEYNOTE SPEAKERS

Nicola Bedlington
Secretary General, European Patients Forum (EPF), Former Director, European Disability Forum, Brussels, Belgium
Serge Bernasconi, MA, MIM
Chief Executive Officer, MedTech Europe, Former CEO, Eucomed, Former CEO, European Diagnostic Manufacturers Association, Brussels, Belgium
Richard Bistrong, MA
Chief Executive Officer, Front-Line Anti-Bribery LLC, Contributing Editor, FCPA Blog, Former Confidential Human Source (CHS) and Cooperating Witness, FBI and US DOJ, Former Cooperating Witness, City of London Police, HMRC and CPS, UK, New York, NY, USA

Giovanni Buttarelli
European Data Protection Supervisor, Former Secretary General, Italian Data Protection Authority, Brussels, Belgium
Charles Cain, JD
Chief, FCPA Unit, US Securities and Exchange Commission (SEC), Washington, DC, USA
Paul Csiszár, JD
Director, DG Competition, European Commission, Brussels, Belgium

Tarek Helou, JD
Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, US Department of Justice, Assistant US Attorney, Northern District of California, Washington, DC, USA
Jan Oliver Huber, DR JUR
General Secretary, Association of the Austrian Pharmaceutical Industry (PHARMIG), Vienna, Austria
José F. Zamarriego Izquierdo, MBA, PhD
Director, Code of Practice Surveillance Unit, Farmaindustria, Chair, EFPIA's Code Committee, Coordinator, EFPIA e4ethics Initiative, Chairman, IFPMA's Code Complaint Procedure Appeal Group, Madrid, Spain

George "Ren" McEachern, CFE, CAMS
Managing Director, Exiger, Former Supervisory Special Agent, International Corruption Squad, US Federal Bureau of Investigation, Washington, DC, USA
Sofie Melis
Senior Manager, Ethics and Compliance, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Geneva, Switzerland
Marie-Claire Pickaert
Deputy Director General, Chief Financial Officer and Ambassador to the Medical Communities, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium

Camilla de Silva
Joint Head of Bribery and Corruption, Serious Fraud Office, London, UK
Heather Simmonds
Director, Prescription Medicines Code of Practice Authority, London, UK

Professor N. Craig Smith
Affiliate Professor of Ethics and Social Responsibility, and Chair, Ethics and Social Responsibility, INSEAD, Academic Director, CSR & Ethics Research Group, INSEAD Social Innovation Centre, Fontainebleau, France
Tamara Tubin
International Compliance Director, Corporate Compliance, Wright Medical Group N.V., Vice Chair, Ethics & Compliance Committee, MedTech Europe, Member, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Zürich, Switzerland

AGENDA-AT-A-GLANCE
Day I: Monday, May 14, 2018
  • Morning Complimentary Precons
  • Luncheon your Own
  • Afternoon Opening Plenary Session
    • Welcome PHARMIG and Co-Chairs
    • C-suite Keynote
    • OECD Update
    • EU Commission Keynote
    • US DOJ and SEC FCPA Update
    • UK SFO Update
    • Annual CCO Roundtable
  • Evening Networking Reception
Day II: Tuesday, May 15, 2018
  • Morning Plenary Session
    • Global Compliance Codes Update
    • Richard Bistrong Behind the Bribe
    • Annual Anti-corruption Roundtable
  • Networking Luncheon
  • Afternoon Mini Summits: Round I
    • Managing Third Party Relationships
    • EU General Data Protection Privacy Update (GDPR)
    • Future of Direct Sponsorships
    • Patient Organizations (EFPIA White Paper)
    • Annual MEA Compliance Update
Day II: continued
  • Afternoon Mini Summits: Round II
    • Outcomes-based Value-added Services
    • Annual Medical Device Compliance Update
    • Social Responsibility: EU Directive 2014/95/EU
    • Evolution of Compliance Programs
    • Annual CEE Compliance Update
  • Afternoon Mini Summits: Round III
    • Social Media Compliance
    • Compliance Monitoring and Risk Assessments
    • Relationships with HCPs, HCOs and Pt Organizations
    • Behavioral Economics in Compliance Programs
    • Compliance Issues in Market Access
Day III: Wednesday, May 16, 2018
  • Morning Closing Plenary Session
    • European Data Protection Supervisor Update
    • IFPMA Update
    • MedTech Europe Update
    • Healthcare Compliance as a Profession
    • Challenges and Opportunities of Pursuing the Healthcare Compliance Profession
    • Embracing Change in the Digital Health Era
    • The Ethics of Artificial Intelligence
  • 12:30 pm Adjournment

FEATURED FACULTY

Ted Acosta, Esq.
Americas Vice Chair, Risk Management, EY; Former Senior Counsel, Office of Inspector General, United States Department of Health and Human Services, New York, NY, USA and Paris, France
John Alexander
Head of European Compliance, Mundipharma International, Former EMEA Director of Compliance, Ortho Clinical Diagnostics, Former Healthcare Compliance Officer, Janssen-Cilag, Cambridge, UK
David Andersen
Partner, Pharmaceuticals and Life Sciences, PwC, London, UK

Michael Bartke, PhD
Former Director Compliance Management, Daiichi Sankyo Europe GmbH, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Munich, Germany
Ann Beasley, JD
Director, Navigant Consulting, Former Senior Vice President, Chief Compliance Officer, Biogen, Former Co-chair, International Pharmaceutical \and Medical Device Compliance Congress, Boston, MA, USA
Liesbeth Bergmans, LLM
Senior Legal Counsel, Teva Pharmaceuticals, Amsterdam, Netherlands

Lee Betteridge
Director, Pharmaceutical and Life Sciences, PwC, London, UK
Julie Bonhomme
Legal Affairs & Compliance Deputy Director, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium
Eduard Castells
Global Head Integrity and Compliance Policies, and Risk Assessment at Novartis, Novartis, Basel, Switzerland

Ceren Aral Desnos, LLM
Interim Director of Legal and Compliance (Consultant), MedTech Europe, Paris, France
Holger Diener
Managing Director, Association of Voluntary Self-Regulation for the Pharmaceutical Industry ("FSA"), Member, Ethics and Compliance Committee and Vice Chair, Code Committee, EFPIA, Member, IFPMA Code Compliance Network, Berlin, Germany
Peter Dieners, Esq.
Partner and Head, Global Healthcare and Life Sciences Group, Clifford Chance, Co-chair, Legal Affairs Focus Group (LA FG), EUCOMED, Co-chair, Compliance Network (CN), EUCOMED, Düsseldorf, Germany

Diva Duong
Global Compliance Solutions Partner, IQVIA, Paris, France
Kip Ebel, MBA
Principal, Fraud Investigation & Dispute Services, EY, New York, NY, USA
Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK

Olga Sanz Escudero
Compliance Advisor, Merck; Former Codes Compliance Officer, Farmaindustria, Madrid, Spain
Karen Eryou
Head, Ethics & Compliance Programs, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Brussels, Belgium
George Fife
Partner, Fraud Investigation & Dispute Services, EY, Former Executive Director, Compliance & Ethics, Bristol-Myers Squibb, Paris, France

Jacques Fontas
Executive Counsel, Compliance Leader Europe, GE Healthcare, Member, Strategic Committee, ETHICS, Paris, France
Geert van Gansewinkel, MSc, MBA, IESE
Managing Partner, Polaris Europe and Asia-Pacific, Polaris BV, Amsterdam, Netherlands
Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA

Cecile Gousset
Head of Compliance Risk Assessment, Policies & Education, Global Ethics & Business Integrity, Sanofi, Paris, France
Ulf H. Grundmann
Partner, FDA and Life Sciences, King & Spalding LLP, Frankfurt am Main, Germany
Joseph W. Henein, PharmD
President and Chief Executive Officer, NewBridge Pharmaceuticals FZ LLC, Dubai, UAE

Casey J. Horton, CFE
Director, Healthcare and Life Sciences Disputes, Regulatory, Compliance and Investigations, Navigant Consulting, Chicago, IL, USA
Els Janssens, LLM
Senior Associate, Baker & McKenzie Habib Al Mulla, Former Legal Adviser, European Medicines Agency, Former Senior Legal Counsel, Johnson & Johnson, Abu Dhabi, UAE
Carl Judge
Partner, Fraud Investigation & Dispute Services, EY, London, UK

Ilknur Kehlibar
Associate Director, Health Care Compliance, Turkey and Partner Markets, Celgene, Istanbul, Turkey
Isaure Kergall-Gayet, DEA-Law, CAPA
Legal Director, France, Amgen, Former VP, Chief Ethics & Compliance Officer, Ipsen, Paris, France
Maria Khoury
Compliance Officer Levant, Roche, Chair, Lebanese Group of International Pharmaceutical Companies, and Iraq LAWG(Local Area Working Group), Beirut, Lebanon

Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA
Tomasz Kruk
Head of Compliance, Vigor Pharma, Former Director International Compliance, Mallinckrodt Pharmaceuticals, Former Director Global Ethics & Compliance, Actavis plc (now Allergan), Zurich, Switzerland
Anita Kyung-Hee Kim-Reinartz
Partner, Fraud Investigation & Dispute Services, EY, Düsseldorf, Germany

Laurence Labey, MD
Ethics and Business Integrity Business Partner for R&D and Chief Medical Office, Sanofi, Paris, France
Evelyne Lemaire, MA
Head of Compliance, Europe & Canada, Takeda Pharmaceuticals International GmbH, Zurich, Switzerland
Abdul Luheshi, MBA
Executive Director, Global Operations, Ethics & Compliance, Astellas Pharma EMEA, Former Vice President, Health Care Compliance, Johnson & Johnson, Chertsey, UK

John McLoughlin, JD
Counsel, Friedman & Wittenstein, Washington, DC
Paul J. Melling, JD
Founding Partner, Baker & McKenzie – CIS, Limited, Moscow, Russia
Laura Nassar
Head of Compliance Middle East, Roche Pharmaceuticals, Former Regional Pharma HCC Officer Emerging Markets, Johnson & Johnson, Beirut, Lebanon

Chrisoula Nikidis
Lead, Canada, Polaris; Former Executive Director, Ethics and Compliance, Innovative Medicines Canada; Former Industry Co-Chair Designate, APEC Biopharmaceutical Working Group on Ethics, Ottawa, Canada
Nicola Orlandi
Head Data Privacy Pharma, Global Privacy Office, Novartis International AG, Former Head of Legal and Compliance, Sandoz S.p.A., Basel, Switzerland
Giota Papamarkou
Global Ethics and Compliance Director, Ipsen, Former EMEA Compliance and Ethics Manager, Bristol-Myers Squibb, Paris, France

Oscar Perdomo
Manager, Pharmaceutical and Life Sciences, PwC, Basil, Switzerland
Nathalie Pirlot
Third Party Compliance Management Lead, UCB, Brussels, Belgium
Madina Plieva, PhD
Legal and Compliance Head, Russia, Bristol-Myers Squibb, Former Legal Director, Association of International Pharmaceutical Manufacturers (AIPM), Former Head of Legal Department, Kutafin Moscow State Law Academy, Moscow, Russia

Ethan M. Posner, JD
Partner, Covington, Former Deputy Associate Attorney General, US Department of Justice, Washington, DC, USA
Uffe Kåre Rasmussen, MSc
Senior Director, Chief Compliance Officer, Corporate Compliance & Corporate Social Responsibility, H. Lundbeck A/S, Copenhagen, Denmark
Ulrich Matthias Reese, Esq.
Partner and Co-Head Global Healthcare, Life Sciences and Chemicals Group, Clifford Chance; Chair of the Pharmaceutical Law Committee of the Association for Intellectual Property and Copyright Law (GRUR), Düsseldorf, Germany

Vivian Robinson, Esq.
Queen's Counsel, Partner, McGuire Woods, Former General Counsel of the UK Serious Fraud Office, Former Head, QEB Hollis Whiteman Chambers, Recorder of the Crown Court and Treasurer of Inner Temple, London, UK
Fabien Roy
Counsel, Hogan & Lovells, Brussels, Belgium
Christine M. Sainvil
Compliance Officer, EthicalMedtech, Manager, Conference Vetting System (CVS), European Medical Technology Industry Association (MedTech Europe), Brussels, Belgium

Thomas J. Schumacher, JD
Vice President and Global Chief, Ethics and Compliance Officer, Medtronic, Awardee, 2017 PwC MedTech Ethical Leadership Award, Fridley, MN, USA
Brian Sharkey, JD
Vice President, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman, Morristown, NJ, USA
Hubertus Stockmann, MBA
Regional Compliance Officer EMEA, Getinge, Former Compliance Officer Performance Material & Merck Group Functions, Merck Group, Frankfurt Am Main, Germany

Michele Tagliaferri, JD
Partner and Lead, Investigations and Compliance Team, Sidley Austin LLP, Brussels, Belgium
Yuet Ming Tham, JD
Partner, Sidley Austin LLP; Former Asia Pacific Regional Compliance Director, Pfizer; Former Deputy Public Prosecutor, Singapore, Hong Kong
Evgeny Tilezhinsky, MBA, PhD
Law and Compliance Lead for the Central and Eastern Europe, Bristol-Myers Squibb, Uxbridge, Middlesex, UK

Dumitru Uta, MD, MBA, CCEP
Ethics and Compliance Director, South Eastern Europe, Eli Lilly and Company, Bucharest, Romania
Pawel Wajszczyk, MBA
Director HCCO Eastern Europe, Russia, CIS MD, Johnson & Johnson, Warsaw, Poland

Mariusz Witalis
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland
Christine Zettlemoyer, JD
Head, Americas Compliance and Global Support, CSL Behring, Former Executive/ Head, Global Compliance Oversight and Monitoring, Merck, King of Prussia, PA, USA

2018 GLOBAL PHARMA COMPLIANCE CONGRESSES

TWELFTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partners: Life Sciences Compliance Update
May 14 - 16, 2018
Hotel Savoyen
Vienna, Austria
www.International PharmaCongress.com
EIGHTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS)
Media Partners: Life Sciences Compliance Update
September 10 - 12, 2018
Singapore
www.Asian PharmaCongress.com
NINETEENTH ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum (PCF)
November 7 - 9, 2018
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
SPONSORED BY:


CO CHAIRS:

Dante Beccaria
Senior Vice President, Global Compliance Officer, Head of Ethics & Business Integrity Department, Sanofi, Paris, France


Stephen Nguyen Duc
Former Area Director, International Operations, Western Europe & Canada, Office of Ethics & Compliance, AbbVie Board Member, Strategic Committee International Society of Healthcare, Ethics, and Compliance Professionals (ETHICS), Rungis, France


Suzanne Durdevic, LLM
Senior Director, General Counsel Europe, Boston Scientific International, Chairs, Legal Affairs Committee, MedTech Europe, Member, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Paris, France


Dominique Laymand, Esq.
Executive Vice President, Chief Ethics and Compliance Officer, Ipsen; Honorary President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France


Roeland Van Aelst
Regional Vice President – HCCO MD&D EMEA & Canada, Office Health Care Compliance and Privacy, Johnson & Johnson, Chairman, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Chairman, MedTech Compliance Network, Brussels, Belgium

GRANTORS:
DIAMOND


SILVER




BRONZE












MEDIA PARTNER:


REGISTRATION DISCOUNTS AVAILABLE TO












CONTINUING EDUCATION CREDITS:
Accounting Professionals: Approved for up to 19.0 NASBA CPE credits.

Attorneys: Pending approval for Pennsylvania CLE credits.

Compliance Professionals: Pending Compliance Certification Board (CCB) approval of CEUs.

Click here for more information.

FOLLOW INTERNATIONAL PHARMA CONGRESS ON




Tweet using #PharmaCongress

INTERNATIONAL PHARMA CONGRESS IS
OTHER INTERNATIONAL PHARMA CONGRESSES

2007 - Brussels


2008 - Paris


2009 - Rome


2010 - Berlin


2007 - Brussels


2008 - Paris


2011 - Singapore


2012 - Budapest


2012 - Shanghai


2012 - São Paulo


2013 - Madrid


2013 - Kuala Lumpur


2014 - Dubai


2014 - Mexico City


2014 - Shanghai


2015 - Manila


2016 - Warsaw


2017 - Lisbon

CONGRESS REGISTRATION

For Congress registration information, visit www.internationalpharmacongress.com/registration/, email registration@hcconferences.com, or call 800-503-8171.


CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
For sponsorship and exhibit information, visit www.internationalpharmacongress.com/promotional-opportunities/, or contact Justin Sorensen, Exhibit Manager, at 206-452-0609 phone, 206-319-5303 fax, or exhibits@hcconferences.com.